Amryt Announces Positive Interim Analysis Data From Open Label Phase of EASE Phase 3 Trial in EB

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Australia ,Canada ,Japan ,United States ,Sydney ,New South Wales ,Israel ,Argentina ,Brazil ,Boston ,Massachusetts ,Saudi Arabia ,Colombia ,Ireland ,Dublin ,American ,Patrick Bursey ,Rory Nealon ,Hypercholesterolaemia Ho ,Joe Wiley ,Dedee Murrell ,Mark Sumeray ,Tim Mccarthy ,Lifesci Advisors ,American Academy Of Dermatology ,Lifesci Communications ,Department Of Dermatology ,American Academy ,Dermatology Annual ,Epidermolysis Bullosa ,Annual Meeting ,Professor Dedee Murrell ,Chief Medical Officer ,Homozygous Familial Hypercholesterolaemia ,Dystrophic Epidermolysis Bullosa ,Transient Permeability Enhancer ,Coronavirus Pandemic ,Business ,Health ,Lifestyle ,Globe Newswire ,